• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

ANGIOGENESIS IN GYNECOLOGIC MALIGNANCY

Research Project

Project/Area Number 09671691
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Obstetrics and gynecology
Research InstitutionKYUSHU UNIVERSITY

Principal Investigator

KAKU Tsunehisa  KYUSHU UNIVERSITY,DEPARTMENT OF GYNECOLOGY AND OBSTETRICS,ASSISTANT PROFESSOR, 医学部, 講師 (60185717)

Co-Investigator(Kenkyū-buntansha) SAKAI Kunihiro  KYUSHU UNIVERSITY,DEPARTMENT OF GYNECOLOGY AND OBSTETRICS,RESEARCH ASSOCIATE, 医学部, 助手 (70264033)
KOBAYASHI Toshiaki  KYUSHU UNIVERSITY,DEPARTMENT OF GYNECOLOGY AND OBSTETRICS,RESEARCH ASSOCIATE, 医学部, 助手 (70260700)
KAMURA Toshiharu  KYUSHU UNIVERSITY,DEPARTMENT OF GYNECOLOGY AND OBSTETRICS,ASSOCIATED PROFESSOR, 医学部, 助教授 (30152870)
Project Period (FY) 1997 – 1998
Project Status Completed (Fiscal Year 1998)
Budget Amount *help
¥3,000,000 (Direct Cost: ¥3,000,000)
Fiscal Year 1998: ¥900,000 (Direct Cost: ¥900,000)
Fiscal Year 1997: ¥2,100,000 (Direct Cost: ¥2,100,000)
KeywordsANGIOGENESIS / MICROVESSEL DENSITY / ENDOMETRIAL CANCER / ADENOCARCINOMA OF UTERINE CERVIX / P53 / FACTOR VIII ANTIGEN / PROGNOSIS / ENDOMETRIAL HYPERPLASIA / Endometrial cancer / Prognostic factor
Research Abstract

To clarify relationship between angiogenesis and growth and spread in gynecologic malignancy, we investigated how MVD is related with several clinicopathological parameters and correlated with metastasis and survival in endometrial carcinoma and adenocarcinoma of the uterine cervix. All hysterectomy specimens were stained immunohistologically for factor VLII-related antigen. MVD was counted in a x200 field (0.785 mm2 per field) in the most active of neovascularization.
In endometriaL carcinoma (85 cases), MVD was significantly correlated with tumor grade, myometrial invasion, and lymph-vascular space invasion. Patients with high MVD (more than 60) had significantly worse PFS and OS than those with low MVD (less than 60). Multivariate analysis showed that MYD correlated significantly and independently with PFS and OS, and MVD is an independent prognostic factor for PFS and OS.
In addition, the relationship of endometrial hyperplasia to endometrial carcinoma concerning angiogenesis was als … More o examined. Twenty-six of 70 (37%) had hyperplasia in the endometrium adjacent to the carcinoma. Significantly more patients with low MVD (less than 60) were in carcinoma with hyperplasia compared to carcinoma without hyperplasia. Significantly more patients with p53 expresssion were in carcinoma without hyperplasia compared to carcinoma with hyperplasia. The presence or absence of hyperplasia seems to be important to assess the biological behavior of endometrial carcinoma, especially concerning angiogenesis and p53 expression.
In adenocarcinoma of the uterine cervix, MVD were significantly increased in invasive area as compared with adjacent non-neoplastic area. MVD was also significantly correlated with ascites cytology. Patients with high MVD (more than 75) had significantly worse PFS and OS than those with low MVD (less than 75). Multivariate analysis showed that MVD correlated significantly and independently with PFS and OS, and MYD is an independent prognostic factor for PFS and OS. Less

Report

(3 results)
  • 1998 Annual Research Report   Final Research Report Summary
  • 1997 Annual Research Report
  • Research Products

    (18 results)

All Other

All Publications (18 results)

  • [Publications] Kaku T: "Angiogenesis in endometrial carcinoma" Cancer. 80. 741-747 (1997)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Kaku T: "Angiogenesis in adenocarcinoma of the uterine cervix" Cancer. 83. 1384-1390 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Sonoda K: "Tumor-associated antigen 22-1-1 expression in the uterine cervical squamous neoplasia." Clinical Cancer Research. 4. 1517-1520 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Mitsumoto M: "Emergence of higher levels of invasive and metastatic properties in the drug resistant cancer cell lines after the repeated administration of cisplatin in tumor-bearing mice." Journal of Cancer Research and Clinical Oncology. 124. 607-614 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Kaku T: "Endometrial carcinoma associated with hyperplasia-Immunohistochemical study of angiogenesis and p53 expression." Gynecologic Oncology. 72. 51-55 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Sakai K: "Comparison of p53,Ki-67 and CD44v6 expression between primary and matched metastatic lesions in ovarian cancer." Gynecologic Oncology. 発表予定. (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Kaku T., et al.: "Angiogenesis in endometrial carcinoma." Cancer. 80. 741-747 (1997)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Sonoda K., et al.: "Tumor-associated antigen 22-1-1 expression in uterine cervical squamous neoplasias." Clin Cancer Res. 4. 1517-1520 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Kaku T., et al.: "Angiogenesis in adenocarcinoma of the uterine cervix." Cancer. 83. 1384-1390 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Mitsumoto M., et al.: "Emergence of higher levels of invasive and metastatic properties in the drug resistant cancer cell lines after the repeated administration of cisplatin in tumor-bearing mice." J Cancer Res Clin Oncol. 124. 607-614 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Kaku T., et al.: "Endometrial carcinoma associated with hyperplasia-Immunohistochemical study of angiogenesis and p53 expression." Gynecol Oncol. 72. 51-55 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Sakai K., et al.: "Comparison of p53, Ki-67 and CD44v6 expression between primary and matched metastatic lesions in ovarian cancer." Gynecol Oncol. (in press).

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Kaku T: "Angiogenesis in adenocarcinoma of the uterine cervix." Cancer. 83. 1384-1390 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] Sonoda K: "Tumor-associated antigen 22-1-1 expression in the uterine cervical squamous neoplasia." Clinical Cancer Research. 4. 1517-1520 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] Mitsumoto M: "Emergence of higher levels of invasive and metastatic properties in the drug resistant cancer cell lines after the repeated administration of cisplatin in tumor-bearing mice." Journal of Cancer Research and Clinical Oncology. 124. 607-614 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] Kaku T: "Endometrial carcinoma associated with hyperplasia-Immunohistochemical study of angiogenesis and p53 expression." Gynecologic Oncology. 72. 51-55 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] Sakai K: "Comparison of p53,Ki-67 and CD44v6 expression between primary and matched metastatic lesions in ovarian cancer." Gynecologic Oncology. (発表予定). (1999)

    • Related Report
      1998 Annual Research Report
  • [Publications] Kaku T: "Angiogenesis in endometrial carcinoma" Cancer. 80. 741-747 (1997)

    • Related Report
      1997 Annual Research Report

URL: 

Published: 1997-04-01   Modified: 2017-10-12  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi